Is Chinook Therapeutics, Inc. (KDNY) a Buy, Sell, or Hold?
NASDAQ : KDNY
Chinook Therapeutics, Inc. — Insider Trades
$40.39 USD
$0.09 (0.22%)
- Volume
- 3.28M
- Average Volume
- 2.05M
- Market Capitalization
- $2.71B
- P/E Ratio
- -14.07
- Dividend Yield
- 0.00%
- Price Target
- $30.00
- Year High
- $40.51
- Year Low
- $18.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.59
Insider Activity Summary (Last 12 Months)
Insiders Buying
44
Insiders Selling
122
Amount of Insider Selling
$11.14M
KDNY Insider Buying/Selling by Quarter
KDNY Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Thomas Dolca | director | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| Thomas Dolca | director | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| Thomas Dolca | director | 2023-08-11 | D-Return | 16.81 | 2023-08-11 |
| Thomas Dolca | director | 2023-08-11 | D-Return | 13.88 | 2023-08-11 |
| Oxtoby Andrew | officer: Chief Commercial Officer | 2023-08-11 | D-Return | 21.82 | 2023-08-11 |
| Oxtoby Andrew | officer: Chief Commercial Officer | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| Krishnan Mahesh | director | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| Krishnan Mahesh | director | 2023-08-11 | D-Return | 16.74 | 2023-08-11 |
| Krishnan Mahesh | director | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 15.14 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 25.27 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 0.42 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 12.9 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 17.59 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-11 | D-Return | 0.35 | 2023-08-11 |
| GRIFFIN MICHELLE RENEE | director | 2023-08-11 | D-Return | 13.88 | 2023-08-11 |
| GRIFFIN MICHELLE RENEE | director | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| GRIFFIN MICHELLE RENEE | director | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| GRIFFIN MICHELLE RENEE | director | 2023-08-11 | D-Return | 16.81 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 13.88 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 52.75 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 85 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 16.45 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 15 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 16.81 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 33 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 62.1 | 2023-08-11 |
| Greenman William Mariner | director | 2023-08-11 | D-Return | 5 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 15.14 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 12.9 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 25.27 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 0.42 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 17.59 | 2023-08-11 |
| Frohlich Tom | officer: Chief Operating Officer | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 15.14 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 25.27 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 12.9 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 0.35 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-08-11 | D-Return | 0.42 | 2023-08-11 |
| Jerel Davis | director | 2023-08-11 | D-Return | 13.88 | 2023-08-11 |
| Jerel Davis | director | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| Jerel Davis | director | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| Jerel Davis | director | 2023-08-11 | D-Return | 16.81 | 2023-08-11 |
| BJERKHOLT ERIC | officer: Chief Financial Officer | 2023-08-11 | D-Return | 15.14 | 2023-08-11 |
| BJERKHOLT ERIC | officer: Chief Financial Officer | 2023-08-11 | D-Return | 13.98 | 2023-08-11 |
| BJERKHOLT ERIC | officer: Chief Financial Officer | 2023-08-11 | D-Return | 25.27 | 2023-08-11 |
| BJERKHOLT ERIC | officer: Chief Financial Officer | 2023-08-11 | D-Return | 12.9 | 2023-08-11 |
| BJERKHOLT ERIC | officer: Chief Financial Officer | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| BJERKHOLT ERIC | officer: Chief Financial Officer | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| Azelby Robert | director | 2023-08-11 | D-Return | 0 | 2023-08-11 |
| Azelby Robert | director | 2023-08-11 | D-Return | 21.6 | 2023-08-11 |
| AKKARAJU SRINIVAS | director | 2023-08-11 | D-Return | 40 | 2023-08-11 |
| AKKARAJU SRINIVAS | director | 2023-08-11 | D-Return | 14.77 | 2023-08-11 |
| AKKARAJU SRINIVAS | director | 2023-08-11 | D-Return | 16.81 | 2023-08-11 |
| AKKARAJU SRINIVAS | director | 2023-08-11 | D-Return | 13.88 | 2023-08-11 |
| King Andrew James | officer: Chief Scientific Officer | 2023-07-29 | M-Exempt | 0 | 2023-08-01 |
| King Andrew James | officer: Chief Scientific Officer | 2023-08-01 | S-Sale | 39.029 | 2023-08-01 |
| King Andrew James | officer: Chief Scientific Officer | 2023-07-29 | M-Exempt | 0 | 2023-08-01 |
| Greenman William Mariner | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Greenman William Mariner | director | 2023-05-30 | S-Sale | 23.3 | 2023-05-31 |
| Greenman William Mariner | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| AKKARAJU SRINIVAS | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| AKKARAJU SRINIVAS | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Haghighat Ross | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Haghighat Ross | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| GRIFFIN MICHELLE RENEE | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| GRIFFIN MICHELLE RENEE | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Jerel Davis | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Jerel Davis | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Thomas Dolca | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| Thomas Dolca | director | 2023-05-26 | M-Exempt | 0 | 2023-05-31 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-04-24 | M-Exempt | 0.42 | 2023-04-26 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-04-24 | M-Exempt | 0.42 | 2023-04-26 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-04-24 | S-Sale | 21.5768 | 2023-04-26 |
| DOBMEIER ERIC | director, officer: President, CEO | 2023-04-24 | S-Sale | 22.2592 | 2023-04-26 |
| Jerel Davis | director | 2023-04-17 | S-Sale | 20.7507 | 2023-04-19 |
| Azelby Robert | director | 2023-04-10 | A-Award | 21.6 | 2023-04-12 |
| Azelby Robert | director | 2023-04-10 | A-Award | 0 | 2023-04-12 |
| Azelby Robert | director: | 2023-04-10 | 0 | 2023-04-12 | |
| King Andrew James | officer: Chief Scientific Officer | 2023-04-03 | M-Exempt | 0.35 | 2023-04-05 |
| King Andrew James | officer: Chief Scientific Officer | 2023-04-03 | M-Exempt | 0.35 | 2023-04-05 |
| King Andrew James | officer: Chief Scientific Officer | 2023-04-03 | S-Sale | 23.3435 | 2023-04-05 |
| Krishnan Mahesh | director | 2023-04-01 | M-Exempt | 0 | 2023-04-04 |
| Krishnan Mahesh | director | 2023-04-01 | M-Exempt | 0 | 2023-04-04 |
| Krishnan Mahesh | director | 2023-04-04 | S-Sale | 23.01 | 2023-04-04 |
| Jerel Davis | director | 2023-03-01 | S-Sale | 22.75 | 2023-03-03 |
| Jerel Davis | director | 2023-03-01 | S-Sale | 22.75 | 2023-03-03 |
| Jerel Davis | director | 2023-03-01 | S-Sale | 22.75 | 2023-03-03 |
| Oxtoby Andrew | officer: Chief Commercial Officer | 2023-02-28 | A-Award | 21.82 | 2023-03-02 |
| Oxtoby Andrew | officer: Chief Commercial Officer | 2023-02-28 | A-Award | 0 | 2023-03-02 |